An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)
Clinical trial NCT00111891 · COMPLETED
Trial details
- NCT number
- NCT00111891
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2005-08-01
- Enrollment
- 575
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.